AB0408 Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis (CAMERA-II): Is it a side-effect of the prednisone or better control of disease activity?
Abstract:Background
In the Computer Assisted Management of Early RA trial-II (CAMERA-II),patients aged ≥18 years with early RA (disease duration <1 year and no prior use of DMARDs) were included and randomized to an MTX-based tight control strategy with either 10 mg of Prednisone (MTX+pred) or placebo (MTX+plac)[1]. The MTX+predgroup had lower disease activity, disability and less erosive joint damage, compared to the MTX+plac group, but gained significantly more in weight than the MTX+plac group: mean 2.9 kg (standard… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.